Renovaro: GEDiCube Joins NVIDIA Inception for Early Cancer Detection in Clinical Trials

 

• GEDiCube, an AI/ML platform that combines differential molecular capabilities with multi-omic analysis to detect cancer early, to join NVIDIA Inception
• Initial focus is on pancreatic cancer: upcoming clinical trials will be an innovative multi-modal approach to building a predictive model

https://www.businesswire.com/news/home/20230830575428/en/GEDiCube-Joins-NVIDIA-Inception-to-Advance-Unique-Platform-for-Early-Cancer-Detection-in-Clinical-Trials